RIDGEFIELD, CT.-- Markland Technologies(www.marklandtech.com) announced the acquisition of gas plasma technology assets from ASI Technology (www.asiplasma.com) with applications for sterilization and decontamination. The assets include three ongoing government contracts and five issued patents with demonstrated applications in the fields of Ballistic Missile Defense, Phased Array Radar and Bio-decontamination.

The purchase price paid for the technology assets is $1 million. The purchase price will be paid as a combination of $150,000 in cash and $850,000 in stock. The acquisition includes all existing and future revenue from ongoing and pending contracts.

The patented technology is based on atmospheric pressure plasmas or room temperature plasmas known as cold plasmas. Cold plasma can destroy deadly microbes lodged on the skin, weapons, medical instruments or clothing. Research has evidenced that plasma can rapidly break down complex chemicals found in nerve gas and deadly biological agents such as anthrax.

Markland will assume all management responsibilities for the three ongoing research and development contracts, and will retain the research and development team associated with the contracts for the US Army, US Navy and US Air Force respectively. The present contract work is focused on implementations, representing the potential to revolutionize present day radar antenna and biohazard decontamination technologies.

Markland CEO Delmar Kintner stated, "We look forward to utilizing the skills of ASI's proven research team to grow these contracts, as well as other Markland contracts. This innovative technology should be very attractive to established DOD contractors and also have potential use in the Homeland Security arena. ASI's technology and team will complement Markland's growth strategy to build upon the existing portfolio of emerging technologies and solutions to address Homeland Security needs."

The asset purchase agreement will be filed with the SEC on Form 8-K. Further details about this transaction will be available in Markland's filings with the Securities and Exchange Commission.

For additional information about Markland Technologies visit the company website: www.marklandtech.com